Noah Labs has recently been selected and today formally joined the Berlin Startup Stipends (BSS) Health track.
Noah Labs has recently been selected and today formally joined the Berlin Startup Stipends (BSS) Health track. The aim of the programme is to promote innovative, technology-related healthcare startups through coaching, training and scholarships, especially in the context of ICT, digitisation and internationalization. As part of the program, Noah Labs is placed with Humboldt University of Berlin but also gains direct access to clinicians and researchers at Berlin's renowned Charité university hospital. During the 1-year program, Noah Labs will be supported with a scholarship, free office space, and mentoring and coaching.
Science & Startups is the association of the four startup services of Freie Universität Berlin, Humboldt-Universität zu Berlin, Technische Universität Berlin and Charité – Universitätsmedizin Berlin. The network bundles years of experience and the resources of the individual, Germany-wide leading startup services Profund Innovation (FU), Humboldt-Innovation (HU), Centre for Entrepreneurship (TU), and BIH Innovations (Charité) in order to develop and offer joint services for science-based start-ups. Science & Startups aims to create a European-leading and globally visible ecosystem for research- and science-based startups in Berlin by 2030.
At Noah Labs, our vision is to enable people to live longer and happier lives despite their cardiovascular condition. We utilize advanced technology to deliver personalized and predictive virtual care at home. Backed by artificial intelligence and machine learning, our solution reduces both mortality and morbidity while enabling cost savings for health systems. Noah Labs develops an AI-powered health analytics platform that combines smart biosensors, machine learning software, and a mobile app for patients. Through digital biomarkers, the system predicts the onset of medical deterioration in advance of a cardiac event, alerts health care providers accordingly, and guides intervention with drug-based therapy optimization.